Skip to main content
Caplight Logo









Neurowyzr

Neurowyzr

Private
SingaporeHealthcare & Life Scienceshttps://neurowyzr.com/

Last Round

Seed

Aug 24, 2023

Total Funding Raised

$3.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neurowyzr is a healthtech company that provides a platform for early detection, diagnosis, and prevention of brain decline using digital neuroscience assessments and AI analytics.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital cognitive assessmentdigital brain function screenDBFSbrain health monitoringSaMDsoftware as a medical devicecognitive decline detectionneurotechmental resilienceworkforce brain healthmedical AIgamified neuroscienceclinical trial softwareB2B SaaSbrain training app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurowyzr Comparables

Compare Neurowyzr with similar companies based on industry and business-model similarity.

Neurowyzr comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Linus Health
83%
BrainCheck
80%
Altoida, Inc.
80%

Neurowyzr Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 24, 2023
SeedJan 10, 2023

Neurowyzr Investors

Notable investors and investment history

Neurowyzr investors
InvestorRounds
Peak XV PartnersSeed
HealthXCapitalSeed
Jungle VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 38% MoM, reaching 9.5K.

  • Aug 24, 2023

    $2.1M round led by Jungle Ventures and Peak XV Partners.

Neurowyzr Filings

Explore SEC and related filing metadata, where available.

Neurowyzr filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neurowyzr's valuation, stock price, and market status.

Is Neurowyzr a public or private company?

Neurowyzr is a private company.

What is the current stock price of Neurowyzr?

Neurowyzr is a private company with no public stock price. No recent secondary market data is available.

How much is Neurowyzr worth (valuation)?

Valuation information for Neurowyzr is not publicly available.

Can I buy Neurowyzr stock?

Neurowyzr shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neurowyzr's last funding round?

Neurowyzr's most recent funding round was Seed on August 24, 2023.

Who are the main investors in Neurowyzr?

Key investors in Neurowyzr include Peak XV Partners, Jungle Ventures.

Will Neurowyzr IPO soon?

No public IPO plans have been announced for Neurowyzr.

How can I track Neurowyzr secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurowyzr's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range15
Year Founded2019
Last FundingAug 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?